These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1550002)

  • 1. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A; Schmaltz S; Calkins H; Morady F
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide.
    Buxton AE; Josephson ME; Marchlinski FE; Miller JM
    J Am Coll Cardiol; 1993 Jan; 21(1):90-8. PubMed ID: 8417082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiloride. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia.
    Duff HJ; Mitchell LB; Kavanagh KM; Manyari DE; Gillis AM; Wyse DG
    Circulation; 1989 Jun; 79(6):1257-63. PubMed ID: 2720927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous arrhythmia detected on ambulatory electrocardiographic recording lacks precision in predicting inducibility of ventricular tachycardia during electrophysiologic study.
    Pratt CM; Thornton BC; Magro SA; Wyndham CR
    J Am Coll Cardiol; 1987 Jul; 10(1):97-104. PubMed ID: 3598001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F; Hess D; Scheinman MM
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents.
    Hook BG; Rosenthal ME; Marchlinski FE; Buxton AE; Josephson ME
    Pacing Clin Electrophysiol; 1992 Mar; 15(3):324-33. PubMed ID: 1372727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
    Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M
    Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Kelly E; Grant G; Ruskin JN
    J Am Coll Cardiol; 1985 Aug; 6(2):298-306. PubMed ID: 4019918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN; Saksena S
    Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.